sub:provenance {
beldoc: dce:description "Approximately 61,000 statements." ;
dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
dce:title "BEL Framework Large Corpus Document" ;
pav:authoredBy sub:_6 ;
pav:version "1.4" .
sub:_5 prov:value "Cyclin D1 selectively inhibits ligand-dependent AR function in several cell types, including breast cancer, bladder cancer, and androgen-independent prostate adenocarcinoma cell lines (54, 55, 56, 57). Cyclin D1 forms a specific complex with the AR, requiring the C terminus of cyclin D1 (55)." ;
prov:wasQuotedFrom pubmed:15331580 .
sub:_6 rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:15331580 ;
prov:wasDerivedFrom beldoc: ,
sub:_5 .
}